325 related articles for article (PubMed ID: 31061116)
1. Chemical disarming of isoniazid resistance in
Flentie K; Harrison GA; Tükenmez H; Livny J; Good JAD; Sarkar S; Zhu DX; Kinsella RL; Weiss LA; Solomon SD; Schene ME; Hansen MR; Cairns AG; Kulén M; Wixe T; Lindgren AEG; Chorell E; Bengtsson C; Krishnan KS; Hultgren SJ; Larsson C; Almqvist F; Stallings CL
Proc Natl Acad Sci U S A; 2019 May; 116(21):10510-10517. PubMed ID: 31061116
[No Abstract] [Full Text] [Related]
2. Inducing vulnerability to InhA inhibition restores isoniazid susceptibility in drug-resistant
Harrison GA; Wang ER; Cho K; Mreyoud Y; Sarkar S; Almqvist F; Patti GJ; Stallings CL
mBio; 2024 Mar; 15(3):e0296823. PubMed ID: 38294237
[TBL] [Abstract][Full Text] [Related]
3. Analysis of interactions of clinical mutants of catalase-peroxidase (KatG) responsible for isoniazid resistance in Mycobacterium tuberculosis with derivatives of isoniazid.
Unissa AN; Doss C GP; Kumar T; Swathi S; Lakshmi AR; Hanna LE
J Glob Antimicrob Resist; 2017 Dec; 11():57-67. PubMed ID: 28743650
[TBL] [Abstract][Full Text] [Related]
4. Insights on the Mechanism of Action of INH-C
Vila-Viçosa D; Victor BL; Ramos J; Machado D; Viveiros M; Switala J; Loewen PC; Leitão R; Martins F; Machuqueiro M
Mol Pharm; 2017 Dec; 14(12):4597-4605. PubMed ID: 29091448
[TBL] [Abstract][Full Text] [Related]
5. Change in prevalence and molecular characteristics of isoniazid-resistant tuberculosis over a 10-year period in China.
Huo F; Lu J; Zong Z; Jing W; Shi J; Ma Y; Dong L; Zhao L; Wang Y; Huang H; Pang Y
BMC Infect Dis; 2019 Aug; 19(1):689. PubMed ID: 31382930
[TBL] [Abstract][Full Text] [Related]
6. Design, Synthesis, and Evaluation of Novel Δ
Sarkar S; Mayer Bridwell AE; Good JAD; Wang ER; McKee SR; Valenta J; Harrison GA; Flentie KN; Henry FL; Wixe T; Demirel P; Vagolu SK; Chatagnon J; Machelart A; Brodin P; Tønjum T; Stallings CL; Almqvist F
J Med Chem; 2023 Aug; 66(16):11056-11077. PubMed ID: 37485869
[No Abstract] [Full Text] [Related]
7. Overview on mechanisms of isoniazid action and resistance in Mycobacterium tuberculosis.
Unissa AN; Subbian S; Hanna LE; Selvakumar N
Infect Genet Evol; 2016 Nov; 45():474-492. PubMed ID: 27612406
[TBL] [Abstract][Full Text] [Related]
8. A virtual screen discovers novel, fragment-sized inhibitors of Mycobacterium tuberculosis InhA.
Perryman AL; Yu W; Wang X; Ekins S; Forli S; Li SG; Freundlich JS; Tonge PJ; Olson AJ
J Chem Inf Model; 2015 Mar; 55(3):645-59. PubMed ID: 25636146
[TBL] [Abstract][Full Text] [Related]
9. Inducing vulnerability to InhA inhibition restores isoniazid susceptibility in drug resistant
Harrison GA; Cho K; Wang ER; Sarkar S; Almqvist F; Patti GJ; Stallings CL
bioRxiv; 2023 Feb; ():. PubMed ID: 36798348
[TBL] [Abstract][Full Text] [Related]
10. Dormant Mycobacterium tuberculosis converts isoniazid to the active drug in a Wayne's model of dormancy.
Raghunandanan S; Jose L; Kumar RA
J Antibiot (Tokyo); 2018 Nov; 71(11):939-949. PubMed ID: 30185901
[TBL] [Abstract][Full Text] [Related]
11. Analytical and clinical performance characteristics of the Abbott RealTime MTB RIF/INH Resistance, an assay for the detection of rifampicin and isoniazid resistant Mycobacterium tuberculosis in pulmonary specimens.
Kostera J; Leckie G; Tang N; Lampinen J; Szostak M; Abravaya K; Wang H
Tuberculosis (Edinb); 2016 Dec; 101():137-143. PubMed ID: 27865383
[TBL] [Abstract][Full Text] [Related]
12. Significance of Coexisting Mutations on Determination of the Degree of Isoniazid Resistance in Mycobacterium tuberculosis Strains.
Karunaratne GHRE; Wijesundera SS; Vidanagama D; Adikaram CP; Perera J
Microb Drug Resist; 2018; 24(6):844-851. PubMed ID: 29683767
[TBL] [Abstract][Full Text] [Related]
13. Mutations of rpoB, katG, inhA and ahp genes in rifampicin and isoniazid-resistant Mycobacterium tuberculosis in Kyrgyz Republic.
Isakova J; Sovkhozova N; Vinnikov D; Goncharova Z; Talaibekova E; Aldasheva N; Aldashev A
BMC Microbiol; 2018 Mar; 18(1):22. PubMed ID: 29566660
[TBL] [Abstract][Full Text] [Related]
14. Impact of isoniazid resistance on virulence of global and south Indian clinical isolates of Mycobacterium tuberculosis.
Ameeruddin NU; Luke Elizabeth H
Tuberculosis (Edinb); 2014 Dec; 94(6):557-63. PubMed ID: 25270728
[TBL] [Abstract][Full Text] [Related]
15. A silent mutation in mabA confers isoniazid resistance on Mycobacterium tuberculosis.
Ando H; Miyoshi-Akiyama T; Watanabe S; Kirikae T
Mol Microbiol; 2014 Feb; 91(3):538-47. PubMed ID: 24354762
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterization of isoniazid-resistant Mycobacterium tuberculosis isolates collected in Australia.
Lavender C; Globan M; Sievers A; Billman-Jacobe H; Fyfe J
Antimicrob Agents Chemother; 2005 Oct; 49(10):4068-74. PubMed ID: 16189082
[TBL] [Abstract][Full Text] [Related]
17. Identification of katG mutations associated with high-level isoniazid resistance in Mycobacterium tuberculosis.
Ando H; Kondo Y; Suetake T; Toyota E; Kato S; Mori T; Kirikae T
Antimicrob Agents Chemother; 2010 May; 54(5):1793-9. PubMed ID: 20211896
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of novel
Valafar F; Ramirez-Busby SM; Torres J; Paul LV; Rodwell TC; Victor TC; Rodrigues C; Gler MT; Crudu V; Catanzaro T
Int J Mycobacteriol; 2015 Mar; 4(Suppl 1):51-52. PubMed ID: 27695670
[TBL] [Abstract][Full Text] [Related]
19. Resistance to Isoniazid and Ethionamide in Mycobacterium tuberculosis: Genes, Mutations, and Causalities.
Vilchèze C; Jacobs WR
Microbiol Spectr; 2014 Aug; 2(4):MGM2-0014-2013. PubMed ID: 26104204
[TBL] [Abstract][Full Text] [Related]
20. [Resistance-conferring mutations of Mycobacterium tuberculosis strains with low level resistance to isoniazid].
Ano H; Matsumoto T; Nagai T; Tamura Y; Yoshida H; Kawahara K; Takamatsu I; Tsuyuguchi I; Takashima T
Kekkaku; 2006 Dec; 81(12):709-13. PubMed ID: 17240915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
